These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10400826)

  • 1. Cytokines in Gaucher's disease.
    Barak V; Acker M; Nisman B; Kalickman I; Abrahamov A; Zimran A; Yatziv S
    Eur Cytokine Netw; 1999 Jun; 10(2):205-10. PubMed ID: 10400826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma.
    Filella X; Blade J; Guillermo AL; Molina R; Rozman C; Ballesta AM
    Cancer Detect Prev; 1996; 20(1):52-6. PubMed ID: 8907203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis.
    Powell JJ; Fearon KC; Siriwardena AK; Ross JA
    Surgery; 2001 May; 129(5):633-40. PubMed ID: 11331456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of serum levels of interleukin-1 family members with disease activity and response to treatment in hairy cell leukemia.
    Barak V; Nisman B; Polliack A; Vannier E; Dinarello CA
    Eur Cytokine Netw; 1998 Mar; 9(1):33-9. PubMed ID: 9613675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
    Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
    Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome.
    Suharti C; van Gorp EC; Setiati TE; Dolmans WM; Djokomoeljanto RJ; Hack CE; ten CH; van der Meer JW
    Thromb Haemost; 2002 Jan; 87(1):42-6. PubMed ID: 11858187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders.
    Libra M; Mangano K; Anzaldi M; Quattrocchi C; Donia M; di Marco R; Signorelli S; Scalia G; Zignego AL; de Re V; Mazzarino MC; Nicoletti F
    Oncol Rep; 2006 May; 15(5):1305-8. PubMed ID: 16596202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
    Tang S; Xiao H; Fan Y; Wu F; Zhang Z; Li H; Yang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):325-9. PubMed ID: 12126553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes.
    Cvetkovic JT; Wallberg-Jonsson S; Stegmayr B; Rantapaa-Dahlqvist S; Lefvert AK
    J Rheumatol; 2002 Feb; 29(2):212-9. PubMed ID: 11838837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable role of interleukin 10 in patients with polymyalgia rheumatica.
    Straub RH; Herfarth HH; Rinkes B; Konecna L; Glück T; von Landenberg P; Georgi J; Helmke K; Schölmerich J; Vaith P; Lang B
    J Rheumatol; 1999 Jun; 26(6):1318-25. PubMed ID: 10381050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass.
    Gormley SM; McBride WT; Armstrong MA; McClean E; MacGowan SW; Campalani G; McMurray TJ
    Cytokine; 2002 Jan; 17(2):61-5. PubMed ID: 11886172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
    Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options.
    Gogos CA; Drosou E; Bassaris HP; Skoutelis A
    J Infect Dis; 2000 Jan; 181(1):176-80. PubMed ID: 10608764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cytokines IL-1beta and IL-1 receptor antagonist, IL-2 and IL-2 soluble receptor-alpha, IL-6 and IL-6 soluble receptor, TNF-alpha and TNF soluble receptor I, and IL10 in drained and systemic blood after major orthopaedic surgery.
    Krohn CD; Reikerås O; Aasen AO
    Eur J Surg; 1999 Feb; 165(2):101-9. PubMed ID: 10192566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
    Muzaffer MA; Dayer JM; Feldman BM; Pruzanski W; Roux-Lombard P; Schneider R; Laxer RM; Silverman ED
    J Rheumatol; 2002 May; 29(5):1071-8. PubMed ID: 12022325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strikingly higher interleukin (IL)-1alpha, IL-1beta and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar IL-2, sIL-2R, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta and interferon IFN-gamma urine levels in healthy females compared to healthy males: protection against urinary tract injury?
    Sadeghi M; Daniel V; Naujokat C; Weimer R; Opelz G
    Clin Exp Immunol; 2005 Nov; 142(2):312-7. PubMed ID: 16232218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma.
    Kuku I; Bayraktar MR; Kaya E; Erkurt MA; Bayraktar N; Cikim K; Aydogdu I
    Mediators Inflamm; 2005 Aug; 2005(3):171-4. PubMed ID: 16106104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma.
    Hatjiharissi E; Terpos E; Papaioannou M; Hatjileontis C; Kaloutsi V; Galaktidou G; Gerotziafas G; Christakis J; Zervas K
    Hematol Oncol; 2004 Dec; 22(4):159-68. PubMed ID: 15991268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.